High CSF levels of NPY are associated with better resilience to trauma in war veterans. Those who develop PTSD show chronic depletion. Intranasal NPY is being investigated as a treatment.
View the study (review) →Central administration of NPY in animal models reduces anxious behavior via Y1 receptors in the amygdala. Opposite effect to CRH (corticotropin-releasing hormone).
Co-released with norepinephrine at sympathetic synapses: a potent vasoconstrictor. Contributes to sustained hypertension in chronic stress.
View the study (review) →Hypothalamic NPY is one of the most potent appetite stimulants known. It is released in response to low leptin and prolonged fasting. Target under investigation in obesity and anorexia.
View the study (review) →Information, not medical advice. Scientific evidence reflects the quality of the studies.